BIOMAT Database Logo BIOMAT Database Logo

Innate immune control of EBV-infected B cells by invariant natural killer T cells. 2013

Brian K Chung, and Kevin Tsai, and Lenka L Allan, and Dong Jun Zheng, and Johnny C Nie, and Catherine M Biggs, and Mohammad R Hasan, and Frederick K Kozak, and Peter van den Elzen, and John J Priatel, and Rusung Tan
Child and Family Research Institute, Immunity in Health and Disease, and Department of Pathology and Laboratory Medicine, University of British Columbia and British Columbia Children's Hospital, Vancouver, BC, Canada; and.

Individuals with X-linked lymphoproliferative disease lack invariant natural killer T (iNKT) cells and are exquisitely susceptible to Epstein-Barr virus (EBV) infection. To determine whether iNKT cells recognize or regulate EBV, resting B cells were infected with EBV in the presence or absence of iNKT cells. The depletion of iNKT cells increased both viral titers and the frequency of EBV-infected B cells. However, EBV-infected B cells rapidly lost expression of the iNKT cell receptor ligand CD1d, abrogating iNKT cell recognition. To determine whether induced CD1d expression could restore iNKT recognition in EBV-infected cells, lymphoblastoid cell lines (LCL) were treated with AM580, a synthetic retinoic acid receptor-α agonist that upregulates CD1d expression via the nuclear protein, lymphoid enhancer-binding factor 1 (LEF-1). AM580 significantly reduced LEF-1 association at the CD1d promoter region, induced CD1d expression on LCL, and restored iNKT recognition of LCL. CD1d-expressing LCL elicited interferon γ secretion and cytotoxicity by iNKT cells even in the absence of exogenous antigen, suggesting an endogenous iNKT antigen is expressed during EBV infection. These data indicate that iNKT cells may be important for early, innate control of B cell infection by EBV and that downregulation of CD1d may allow EBV to circumvent iNKT cell-mediated immune recognition.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D008232 Lymphoproliferative Disorders Disorders characterized by proliferation of lymphoid tissue, general or unspecified. Duncan's Syndrome,X-Linked Lymphoproliferative Syndrome,Duncan Disease,Epstein-Barr Virus Infection, Familial Fatal,Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males,Familial Fatal Epstein-Barr Infection,Immunodeficiency 5,Immunodeficiency, X-Linked Progressive Combined Variable,Lymphoproliferative Disease, X-Linked,Lymphoproliferative Syndrome, X-Linked, 1,Purtilo Syndrome,X-Linked Lymphoproliferative Disease,X-Linked Lymphoproliferative Disorder,Disease, Duncan,Disease, X-Linked Lymphoproliferative,Diseases, X-Linked Lymphoproliferative,Disorder, Lymphoproliferative,Disorder, X-Linked Lymphoproliferative,Disorders, Lymphoproliferative,Disorders, X-Linked Lymphoproliferative,Epstein Barr Virus Induced Lymphoproliferative Disease In Males,Epstein Barr Virus Infection, Familial Fatal,Familial Fatal Epstein Barr Infection,Immunodeficiency 5s,Immunodeficiency, X Linked Progressive Combined Variable,Lymphoproliferative Disease, X Linked,Lymphoproliferative Diseases, X-Linked,Lymphoproliferative Disorder,Lymphoproliferative Disorder, X-Linked,Lymphoproliferative Disorders, X-Linked,Lymphoproliferative Syndrome, X-Linked,Lymphoproliferative Syndromes, X-Linked,Purtilo Syndromes,Syndrome, Purtilo,Syndrome, X-Linked Lymphoproliferative,Syndromes, Purtilo,Syndromes, X-Linked Lymphoproliferative,X Linked Lymphoproliferative Disease,X Linked Lymphoproliferative Disorder,X Linked Lymphoproliferative Syndrome,X-Linked Lymphoproliferative Diseases,X-Linked Lymphoproliferative Disorders,X-Linked Lymphoproliferative Syndromes
D002450 Cell Communication Any of several ways in which living cells of an organism communicate with one another, whether by direct contact between cells or by means of chemical signals carried by neurotransmitter substances, hormones, and cyclic AMP. Cell Interaction,Cell-to-Cell Interaction,Cell Communications,Cell Interactions,Cell to Cell Interaction,Cell-to-Cell Interactions,Communication, Cell,Communications, Cell,Interaction, Cell,Interaction, Cell-to-Cell,Interactions, Cell,Interactions, Cell-to-Cell
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D014066 Palatine Tonsil A round-to-oval mass of lymphoid tissue embedded in the lateral wall of the PHARYNX. There is one on each side of the oropharynx in the fauces between the anterior and posterior pillars of the SOFT PALATE. Tonsil,Tonsil, Palatine,Palatine Tonsils,Tonsils,Tonsils, Palatine
D051821 Lymphoid Enhancer-Binding Factor 1 A T-cell factor that plays an essential role in EMBRYONIC DEVELOPMENT. LEF-1 Transcription Factor,T Cell-Specific Transcription Factor 1-alpha,LEF 1 Transcription Factor,Lymphoid Enhancer Binding Factor 1,T Cell Specific Transcription Factor 1 alpha,Transcription Factor, LEF-1
D055610 Antigens, CD1d A major histocompatibility complex class I-like protein that contains an IMMUNOGLOBULIN C1-SET DOMAIN. It plays a unique role in the presentation of lipid ANTIGENS to NATURAL KILLER T-CELLS. CD1d Antigen,Cd1d Molecule,Antigen, CD1d,CD1d Antigens

Related Publications

Brian K Chung, and Kevin Tsai, and Lenka L Allan, and Dong Jun Zheng, and Johnny C Nie, and Catherine M Biggs, and Mohammad R Hasan, and Frederick K Kozak, and Peter van den Elzen, and John J Priatel, and Rusung Tan
Innate-like recognition of microbes by invariant natural killer T cells.
August 2009, Current opinion in immunology,
Brian K Chung, and Kevin Tsai, and Lenka L Allan, and Dong Jun Zheng, and Johnny C Nie, and Catherine M Biggs, and Mohammad R Hasan, and Frederick K Kozak, and Peter van den Elzen, and John J Priatel, and Rusung Tan
Invariant natural killer T cells: bridging innate and adaptive immunity.
January 2011, Cell and tissue research,
Brian K Chung, and Kevin Tsai, and Lenka L Allan, and Dong Jun Zheng, and Johnny C Nie, and Catherine M Biggs, and Mohammad R Hasan, and Frederick K Kozak, and Peter van den Elzen, and John J Priatel, and Rusung Tan
Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
June 2009, Tissue antigens,
Brian K Chung, and Kevin Tsai, and Lenka L Allan, and Dong Jun Zheng, and Johnny C Nie, and Catherine M Biggs, and Mohammad R Hasan, and Frederick K Kozak, and Peter van den Elzen, and John J Priatel, and Rusung Tan
Invariant natural killer T cells balance B cell immunity.
January 2021, Immunological reviews,
Brian K Chung, and Kevin Tsai, and Lenka L Allan, and Dong Jun Zheng, and Johnny C Nie, and Catherine M Biggs, and Mohammad R Hasan, and Frederick K Kozak, and Peter van den Elzen, and John J Priatel, and Rusung Tan
Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells.
March 2004, The Journal of experimental medicine,
Brian K Chung, and Kevin Tsai, and Lenka L Allan, and Dong Jun Zheng, and Johnny C Nie, and Catherine M Biggs, and Mohammad R Hasan, and Frederick K Kozak, and Peter van den Elzen, and John J Priatel, and Rusung Tan
Homeostatic regulation of marginal zone B cells by invariant natural killer T cells.
January 2011, PloS one,
Brian K Chung, and Kevin Tsai, and Lenka L Allan, and Dong Jun Zheng, and Johnny C Nie, and Catherine M Biggs, and Mohammad R Hasan, and Frederick K Kozak, and Peter van den Elzen, and John J Priatel, and Rusung Tan
Adipose invariant natural killer T cells.
July 2014, Immunology,
Brian K Chung, and Kevin Tsai, and Lenka L Allan, and Dong Jun Zheng, and Johnny C Nie, and Catherine M Biggs, and Mohammad R Hasan, and Frederick K Kozak, and Peter van den Elzen, and John J Priatel, and Rusung Tan
Harnessing invariant natural killer T cells to control pathological inflammation.
January 2022, Frontiers in immunology,
Brian K Chung, and Kevin Tsai, and Lenka L Allan, and Dong Jun Zheng, and Johnny C Nie, and Catherine M Biggs, and Mohammad R Hasan, and Frederick K Kozak, and Peter van den Elzen, and John J Priatel, and Rusung Tan
Activation and Regulation of B Cell Responses by Invariant Natural Killer T Cells.
January 2018, Frontiers in immunology,
Brian K Chung, and Kevin Tsai, and Lenka L Allan, and Dong Jun Zheng, and Johnny C Nie, and Catherine M Biggs, and Mohammad R Hasan, and Frederick K Kozak, and Peter van den Elzen, and John J Priatel, and Rusung Tan
Development of invariant natural killer T cells.
April 2016, Current opinion in immunology,
Copied contents to your clipboard!